CD79A and plasma cell myeloma: Transcriptomic analysis in a panel of 31 myeloma cell lines and 25 patient samples showed an enrichment of specific B-cell genes and specific B cell surface markers, including CD20 and CD79A in venetoclax- sensitive myeloma cells (121).